✦ LIBER ✦

[788] A PROSPECTIVE COMPARATIVE STUDY OF PROPHYLACTIC OR THERAPEUTIC USE OF LAMIVUDINE FOR CHEMOTHERAPY-ASSOCIATED HEPATITIS B (HBV) REACTIVATION IN NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS

✍ Scribed by C. Hsu; C.A. Hsiung; I.J. Su; W.S. Hwang; M.C. Wang; S.F. Lin; T.H. Lin; H.H. Hsiao; J.H. Young; M.C. Chang; M.T. Huang; Y.M. Liao; C.C. Li; H.B. Wu; T.Y. Chao; T.W. Liu; A.L. Cheng; P.T. Chen

Book ID: 117375877
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 142 KB
Volume: 46
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(07)62386-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A revisit of prophylactic lamivudine for

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

✍ Chiun Hsu; Chao A. Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying cancer patients who undergo chemotherapy, but the optimal treatment protocol remains undetermined. In this study, HBV carriers with newly diagnosed non-Hodgkin's lymphoma (NHL) who underwent chemotherapy were ran

A single-center, prospective and randomi

A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?

✍ Meijun Long; Weijuan Jia; Shunrong Li; Liang Jin; Jiannan Wu; Nanyan Rao; Huiyi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 188 KB